Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.6349
+0.0732 (13.03%)
At close: Nov 21, 2025, 4:00 PM EST
0.6174
-0.0175 (-2.76%)
After-hours: Nov 21, 2025, 7:56 PM EST
Harvard Bioscience Revenue
Harvard Bioscience had revenue of $20.59M in the quarter ending September 30, 2025, a decrease of -6.28%. This brings the company's revenue in the last twelve months to $87.37M, down -10.60% year-over-year. In the year 2024, Harvard Bioscience had annual revenue of $94.14M, down -16.14%.
Revenue (ttm)
$87.37M
Revenue Growth
-10.60%
P/S Ratio
0.28
Revenue / Employee
$246,115
Employees
355
Market Cap
28.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94.14M | -18.12M | -16.14% |
| Dec 31, 2023 | 112.25M | -1.09M | -0.96% |
| Dec 31, 2022 | 113.34M | -5.57M | -4.68% |
| Dec 31, 2021 | 118.90M | 16.80M | 16.46% |
| Dec 31, 2020 | 102.10M | -14.08M | -12.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HBIO News
- 15 days ago - Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Harvard Bioscience Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 22 days ago - Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET - GlobeNewsWire
- 2 months ago - Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors - GlobeNewsWire
- 3 months ago - Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewsWire